Vnitr Lek 2006, 52(10):947-953

Contemporary theories concerning chronic lymphocytic thyroiditis

Z. Límanová*, J. Jiskra
III. interní klinika 1. lékařské fakulty UK a VFN, Praha, přednosta prof. MUDr. Štěpán Svačina, DrSc., MBA

Review of contemporary theories and hypothesis concerning chronic lymphycytic thyroiditis is presented. The origin of the disease depends on various factors: genetics, immunological conditions, cytokins, iodine supply, hormones, TSH and its receptors, apoptosis activation and inhibition. The environmental conditions include goitrogens, selenium, polutants and other still unknown factors. Whether the disease will be accompanied with goiter, nodules or thyroid atrophy with functional disorder is still not evident.

Keywords: thyroid; lymphocytic thyroiditis; cytokins

Received: June 21, 2006; Published: October 1, 2006  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Límanová Z, Jiskra J. Contemporary theories concerning chronic lymphocytic thyroiditis. Vnitr Lek. 2006;52(10):947-953.
Download citation

References

  1. Zamrazil V. Vliv věku na štítnou žlázu. DMEV 2001; 1: 46-52.
  2. Límanová Z, Zamrazil V. Má být zaveden sreening funkčních tyreoidálních onemocnění u dospělých? DMEV 2004; 7: 124-130.
  3. Volpé R. Thyroiditis: current views of pathogenesis. Med Clin North Am 1975; 59: 1163-1175. Go to original source... Go to PubMed...
  4. Jansson R. Autoimmune thyroiditis. Uppsala: Acta Universitatis Upsaliensis 1984 (492): 7-71.
  5. Šterzl I, Zamrazil V. Imunoendokrinologie. In: Stárka L et al. Aktuální endokrinologie. Praha: Maxdorf Jessenius 1999: 598-619.
  6. Tanriverdi F, Silveira LFG, MacColl GS et al. The hypothalamic-pituitary-gonadal axis: immune function and autoimmunity. Journal of Endocrinology 2003; 176: 293-304. Go to original source... Go to PubMed...
  7. Fox HS. Androgen treatment prevents diabetes in nonobese diabetic mice. Journal of Experimental Medicine 1992; 175: 1409-1412. Go to original source... Go to PubMed...
  8. Krejsek J, Kopecký O. Autoimunitní imunopatologické stavy, indukce, efektorové mechanismy. In: Krejsek J, Kopecký O. Klinická imunologie. Hradec Králové: Nucleus 2004: 571-596.
  9. Ansari MA, Dhar M, Spieker S et al. Modulation of diabetes with gonadotropin-releasing hormone antagonists in the nonobese mouse model of autoimmune diabetes. Endocrinology 2004; 145: 337-342. Go to original source... Go to PubMed...
  10. Hsu CC, Lin YS, Wang ST et al. Immunomodulation in women with endometriosis receiving GnRH agonist. Obstetrics and Gynecology 1997; 89: 993-998. Go to original source... Go to PubMed...
  11. Amino N, Hidaka Y, Takano T et al. Possible induction of Graves' disease and painless thyroiditis by gonadotropin-releasing hormone analogues. Thyroid 2003; 13: 815-818. Go to original source... Go to PubMed...
  12. Jannsen OE, Mehlmauer N, Hahn S et al. High prevalence of autoimmune thyroiditis in patients with polycystic ovary syndrome. Eur J Endocrinol 2004; 150: 363-369. Go to original source... Go to PubMed...
  13. Belvisi L, Bombelli F, Sironi L et al. Organ-specific autoimmunity in patients with premature ovarian failure. Journal of Endocrinologicel Investigation 1993; 16: 889-892. Go to original source... Go to PubMed...
  14. Hanafusa T, Pujol-Borrell R, Chiovato L et al. Aberrant expression of HLA-DR antigen on thyrocytes in Grave's disease: relevance for autoimmunity. Lancet 1983; 2: 1111-1115. Go to original source... Go to PubMed...
  15. Phenekos C, Vryonidou A, Gritzapis AD et al. Th1 and Th2 serum cytokine profiles characterize patients with Hashimoto's thyroiditis (Th1) and Grave's disease (Th2). Neuroimmunomodulaion 2004; 150: 605-618. Go to original source... Go to PubMed...
  16. Yu S, Sharp GC, Braley-Mullen H. Dual roles for IFN-γ, but nor for IL-4, in spontaneous autoimmune thyroiditis in NOD.H-2h4 mice. J Immunol 2002; 169: 3999-4007. Go to original source... Go to PubMed...
  17. Wang SH, Bretz JD, Phelps E et al. A unique combination of inflammatory cytokines enhances apoptosis of thyroid follicular cells and transforms nondestructive to destructive thyroiditis in experimental autoimmune thyroiditis. J Immunol 2002; 168: 2470-2474. Go to original source... Go to PubMed...
  18. Tourneur L, Damotte D, Marion S et al. IL-10 is necessary for FasL-induced protection from experimental autoimmune thyroiditis but nor for FasL-induced immune deviation. Eur J Immunol 2002; 32: 1292-1299. Go to original source...
  19. Lee M, Ko KS, Oh S et al. Prevention of autoimmune insulitis by delivery of a chimeric plasmid encoding interleukin-4 and interleukin-10. J Control Release 2003; 88: 333-342. Go to original source... Go to PubMed...
  20. Zhang ZL, Shen SX, Lin B et al. Intramuscular injection of interleukin-10 plasmid DNA prevented autoimmune diabetes in mice. Acta Pharmacol Sin 2003; 24: 751-756.
  21. Franzen A, Piek E, Westermark B et al. Expression of transforming growth factor-β1, activin A, and their receptors in thyroid follicle cells: negative regulation of thyrocyte growth and function. Endocrinology 1999; 140: 4300-4310. Go to original source... Go to PubMed...
  22. Devendra D, Yu L, Eisenbarth GS. Endocrine antibodies. Clin Lab Med 2004; 24: 275-303. Go to original source... Go to PubMed...
  23. Jiang H, Chese L. Regulation of immune responses by T cell. N Engl J Med 2006; 354: 1166-1176. Go to original source... Go to PubMed...
  24. Valmori D, Merlo A, Souleimanian NE et al. A peripheral circulating compartment of natural naive CD4 Tregs. J Clin Invest 2005; 115: 1953-1962. Go to original source... Go to PubMed...
  25. Eisenbarth GS, Gottlieb PA. Autoimmune polyendocrine syndromes. N Engl J Med 2004; 350: 2068-2079. Go to original source... Go to PubMed...
  26. Kapras J, Kohoutová M. Apoptóza. In: Kapras J, Kohoutová M. Kapitoly z lékařské biologie a genetiky III. Praha: Karolinum 1999: 84-90.
  27. Sršeň Š, Sršňová K. Apoptóza. In: Sršeň Š, Sršňová K (eds). Základy klinickej genetiky a jej molekulárna podstata. Martin: Osveta 2000: 46-47.
  28. Dittmar M, Kahaly J. Immunoregulatory and susceptibility genes in thyroid and polyglandular autoimmunity. Thyroid 2005; 12: 239-250. Go to original source... Go to PubMed...
  29. Sakai K, Shirasawa S, Ishikawa N et al. Identification of susceptibility loci for autoimmune thyroid disease to 5q31-q33 and Hashimoto's thyroiditis to 8q23-q24 by multipoint affected sib-pair linkage analysis in Japanese. Hum Mol Genet 2001; 10: 1379-1386. Go to original source... Go to PubMed...
  30. Gough SC. The genetics of Graves' disease. Endocrinol Metab Clin North Am 2000; 29: 255-266. Go to original source... Go to PubMed...
  31. Antonelli A, Ferri C, Pampana A et al. Thyroid disorders in chronic hepatitis C. Am J Med 2004; 117: 10-13. Go to original source... Go to PubMed...
  32. Prummel MF, Strieder T, Wiersinga WM. The environment and autoimmune thyroid diseases. Eur J Endocrinol 2004; 150: 605-618. Go to original source... Go to PubMed...
  33. Franceschi F, Satta MA, Mentella MC et al. Helicobacter pylori infection in patients with Hashimoto's thyroiditis. Helicobacter 2004; 9: 369-372. Go to original source... Go to PubMed...
  34. Tomasi PA, Dore MP, Fanciulli G et al. Is there anything to the reported association between Helicobacter pylori infection and autoimmune thyroiditis? Dig Dis Sci 2005; 50: 385-388. Go to original source... Go to PubMed...
  35. Bertalot G, Montresor G, Tampieri M et al. Decrease in thyroid autoantibodies after eradication of Helicobacter pylori infection. Clin Endocrinol (Oxf) 2004; 61: 650-652. Go to original source... Go to PubMed...
  36. Antonelli A, Rotondi M, Fallahi P et al. Increase of interferon-gamma inducible alpha chemokine CXCL10 but not beta chemokine CCL2 serum levels in chronic autoimmune thyroiditis. Eur J Endocrinol 2005; 152: 171-177. Go to original source... Go to PubMed...
  37. Kuitunen M, Saukkonen T, Ilonen J et al. Intestinal permeability to mannitol and lactulose in children with type 1 diabetes with the HLA-DQB1*02 allele. Autoimmunity 2002; 35: 365-368. Go to original source... Go to PubMed...




Vnitřní lékařství

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.